Clinical Trials
2 trialsNCT00433511 2026-05-29
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT06805084 2025-02-03
H/ACA-ER
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Active not recruiting